When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases

Dalila Boi1, Elisabetta Rubini1, Sara Breccia1

  • 1Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.

Insights

Myc transcription factors regulate cell processes, and their overexpression drives cancer. Kinases interact with Myc, controlling its activity and turnover, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Myc transcription factors are crucial regulators of cell proliferation, stem cell pluripotency, metabolism, and apoptosis.
  • Myc overexpression is frequently observed in various cancers, driving tumor cell proliferation.
  • Myc and associated kinases exhibit a mutual regulatory interplay, influencing transcriptional activity and protein turnover.

Purpose of the Study:

  • To explore the cross-regulation between Myc and its associated protein kinases.
  • To elucidate the mechanisms underlying Myc and kinase interactions at transcriptional and post-translational levels.
  • To identify potential therapeutic strategies by reviewing the indirect effects of kinase inhibitors on Myc.

Main Methods:

  • Literature review focusing on the interplay between Myc and kinases.
  • Analysis of transcriptional and post-translational regulatory mechanisms.
  • Examination of existing kinase inhibitor data for indirect effects on Myc.

Main Results:

  • Myc and kinases form a regulatory loop, with kinases phosphorylating Myc to modulate its activity.
  • Kinases tightly control Myc protein levels through a balance of translation and degradation.
  • Kinase inhibitors show indirect effects on Myc, suggesting potential for combined cancer therapies.

Conclusions:

  • The intricate cross-regulation between Myc and kinases offers insights into cancer development.
  • Targeting this Myc-kinase axis presents a promising avenue for novel cancer therapeutics.
  • Understanding these interactions can lead to the development of combined therapeutic approaches for cancer treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K